Not sure where to start? Get matched →
BPC-157 (Injectable)
Popular
Recovery

BPC-157 (Injectable)

Accelerated healing & gut health

The pepti Pen cartridge for this treatment is sold out right now. The vial is the same medication at our best price.

Choose your strength

Every strength is a 4-week supply. A higher strength means more medication per dose on the same monthly cycle. Your provider confirms the dose at review.

All-in monthly price · 5mg

$209

No membership fee · this is the full price · free shipping · avg 4-week supply

Medication, provider care, labs & dose adjustments — all in one price.
~28-day supply. Your provider sets your exact dose, so yours may vary — your refill arrives as you finish the last one.
Start assessment

Add in-depth bloodwork

Optional — add a physician-reviewed at-home blood panel to your plan.

At-home kit (1 device)+$149

Your sex-hormone baseline plus the safety markers that matter on therapy — blood counts, liver and kidney function — from one painless upper-arm device. Matched to your sex (PSA for men; progesterone & FSH for women). No needle, no clinic, physician-reviewed.

Money-back guarantee
Free AI care assistant
HSA/FSA accepted
Cancel anytime
Free shipping

This treatment requires licensed provider review and approval. Treatment is not guaranteed. If prescribed, medication is fulfilled by a licensed U.S. pharmacy where permitted by law. Compounded medications are not FDA-approved or FDA-cleared.

Dr. Gene
Physician Reviewed

Reviewed by Dr. Gene, MD · Board-certified Family Medicine

Every Pepti prescription is reviewed by a licensed U.S. physician before it's dispensed — and only provided if clinically appropriate.

About

BPC-157 (Injectable)

Body Protection Compound-157 supports tissue healing, gut repair, and recovery from injuries.

Benefits
Injury recovery
Gut healing
Reduced inflammation
Joint support
Supply per fill
28-day

About a 4-week supply supply at the standard prescribed dose — your physician confirms exact dosing.

Physician review
24 hrs

A licensed US physician reviews your intake and prescribes when appropriate.

FDA-registered pharmacy
503A

Compounded fresh at a US pharmacy and shipped cold-chain to your door.

Shipping, always
Free

Every order ships free — medication, physician care and refills, one all-in price.

Formulation
Injectable vial5 mL · 1 mg/mL
BPC-1575 mg
Pepti Pen cartridge3 mL cartridge (300 units) · 3 mg/mL
BPC-1579 mg

Amounts shown are per unit. Compounded fresh at a US FDA-registered pharmacy.

Quality

Every batch independently tested

Every medication batch dispensed through Pepti is independently tested by a qualified third-party laboratory for applicable quality and safety standards before the pharmacy releases it. Batches are tested to the same standard used by 503B outsourcing facilities.

USP <71>
Sterility

Confirms the finished preparation is free of viable microorganisms.

USP <85>
Bacterial endotoxins

Screens for endotoxins that can cause fever or inflammatory reactions.

Assay
Potency

Verifies the labeled concentration of the active peptide is what is in the vial.

HPLC
Purity

Checks the active peptide against impurities and degradation products.

Mass spectrometry
Identity

Confirms the peptide in the vial is the correct molecule.

USP <791>
pH

Confirms the solution sits within the range specified for injection.

USP <788>
Particulate matter

Checks the finished vial for visible and sub-visible particles.

USP <1207>
Container closure integrity

Confirms the vial seal holds so sterility is maintained through the beyond-use date.

Recent lots
  • Lot 100526-BPC-2

    Tested 2026-10-07 · Biolink Life Sciences Carolinas

    Sterility

    Sterile

    Endotoxin

    <2 EU/mL

    Potency

    99.1%

  • Lot 100526-BPC-3

    Tested 2026-10-07 · Biolink Life Sciences Carolinas

    Sterility

    Sterile

    Endotoxin

    <2 EU/mL

    Potency

    99.8%

  • Lot 092826-BPC-2

    Tested 2026-09-30 · Biolink Life Sciences Carolinas

    Sterility

    Sterile

    Endotoxin

    <2 EU/mL

    Potency

    99.7%

Compounded by licensed U.S. pharmacies. Prescribed by licensed medical providers. Shipped directly to patients.Documentation available upon request →View lab results by lot →
Your protocol

How BPC-157 is prescribed.

Who it's for
  • Adults recovering from tendon, ligament, muscle, or joint injuries
  • Patients with gut discomfort or inflammation their physician wants to support
  • People whose training or work keeps re-aggravating the same area

Your physician decides whether BPC-157 is appropriate for you after reviewing your intake and labs.

Directions & duration

Inject 0.18 mL (18 units) subcutaneously once daily as directed.

Cycle. Ongoing monthly treatment. Most patients notice the most change in the first two months and continue for lasting support.
Ready for more? When you're ready for more, ask your physician to move you up to the next strength. Approved steps are charged at the price difference and applied to your next fill.
Directions shown are the pharmacy's standard for this preparation. Your prescription label is the final word.
What's included
  • Licensed physician review of your intake, history, and labs
  • Medication compounded to your prescription by a PCAB-accredited, FDA-registered pharmacy
  • Every batch independently tested before release
  • Sterile syringes and alcohol prep pads for injectables
  • Tracked delivery to your door, refills on schedule
  • Message your physician anytime; dose changes without an appointment
Storage & handling
  • Store refrigerated (36–46°F / 2–8°C) at all times, including before first use.
  • One vial is your monthly supply. A fresh vial ships every 28 days on your refill schedule, so you're always well inside the beyond-use date on your label.
  • Protect from light. Wipe the stopper with an alcohol pad before every draw.
  • Dispose of syringes in the sharps container per the included instructions.
What to expect

A typical course of BPC-157.

TimeframeWhat patients commonly report
Weeks 1–2Many patients report less soreness and easier movement in the injured or inflamed area.
Weeks 3–6Recovery-focused changes tend to build with consistent daily use; this is where most patients notice the difference.
Weeks 6–12 and onRecovery benefits tend to hold with continued use. Many patients stay on it long term for ongoing support, with the dose adjusted by their physician.
Individual results vary. Compounded medications are not FDA-approved; a licensed physician determines whether treatment is appropriate and monitors your progress.
The full reference

Everything published
about BPC-157.

How it is described to work, pathway by pathway. What the research shows and what it does not. Where it stands with the FDA, dated and sourced.

Read the reference
34
References

peer-reviewed, each verified on PubMed

15
Sections

mechanism, evidence, dosing, safety, FAQ

Sep 24
FDA status verified

2026 · checked against fda.gov, not memory

The science

How BPC-157 works, and what the research shows.

How it works

BPC-157 (Body Protection Compound) is a 15-amino-acid peptide derived from a protective protein in human gastric juice.

It promotes angiogenesis (new blood vessel formation), upregulates growth hormone receptors at injury sites, and accelerates the healing of tendons, ligaments, muscle, and the GI tract lining.

Clinical evidence
  • Decades of preclinical research support BPC-157's role in tissue regeneration.

  • Animal studies have demonstrated accelerated tendon-to-bone healing, Achilles tendon repair, and gut barrier protection in colitis and IBD models.

    Chang et al., J Appl Physiol 2011Krivic et al., J Orthop Res 2006Sikiric et al., Curr Pharm Des 2011
  • The mechanism appears to involve upregulation of VEGF and FAK-paxillin signaling at injury sites, driving angiogenesis and fibroblast migration.

  • Human clinical trials are limited, and BPC-157 remains an investigational compound prescribed off-label by US-licensed physicians under 503A compounding pathways.

Full references with PubMed links are listed further down the page.

References

  1. Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts · Molecules (2014) · PMID 25415472
  2. Krivic A, Anic T, Seiwerth S, et al.. Achilles detachment of rat and stable gastric pentadecapeptide BPC 157 · Journal of Orthopaedic Research (2006) · PMID 16583442
  3. Sikiric P, Seiwerth S, Rucman R, et al.. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract · Current Pharmaceutical Design (2011) · PMID 21548867
  4. Cerovecki T, Bojanic I, Brcic L, Radic B, et al.. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat · J Orthop Res (2010) · PMID 20225319
  5. Sikiric P, Seiwerth S, Rucman R, Turkovic B, et al.. Stable gastric pentadecapeptide BPC 157-NO-system relation · Curr Pharm Des (2014) · PMID 23755725
  6. Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H · Drug Test Anal (2017) · PMID 28035768
  7. Thomas A, Görgens C, Guddat S et al.. Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry · J Sep Sci (2016) · PMID 26578461
  8. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL et al.. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale · Pain (2001) · PMID 11690728
  9. Meyer JD, Ho B, Manning MC. Effects of conformation on the chemical stability of pharmaceutically relevant polypeptides · Pharm Biotechnol (2002) · PMID 11987755
  10. Xu C, Sun L, Ren F, Huang P, et al.. Preclinical Safety Evaluation of Body Protective Compound-157, a Potential Drug for Treating Various Wounds · Regul Toxicol Pharmacol (2020) · PMID 32334036
  11. He L, Feng D, Guo H, et al.. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs · Front Pharmacol (2022) · PMID 36588717
  12. Lee E, Padgett B. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain · Altern Ther Health Med (2021) · PMID 34324435
  13. Lee E, Walker C, Ayadi B. Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study · Altern Ther Health Med (2024) · PMID 39325560
  14. Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study · Altern Ther Health Med (2025) · PMID 40131143
  15. Sikiric P, Seiwerth S, Rucman R et al.. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157 · Curr Pharm Des (2013) · PMID 22950504
  16. Klicek R, Kolenc D, Suran J et al.. Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability · J Physiol Pharmacol (2013) · PMID 24304574
  17. Grgic T, Grgic D, Drmic D et al.. Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula · Eur J Pharmacol (2016) · PMID 26875638
  18. Sikiric P, Drmic D, Sever M et al.. Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy · Curr Pharm Des (2020) · PMID 32329684
  19. Lojo N, Rasic Z, Zenko Sever A et al.. Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats · PLoS One (2016) · PMID 27627764
  20. Park JM, Lee HJ, Sikiric P et al.. BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection · Curr Pharm Des (2020) · PMID 32445447
  21. Bajramagic S, Sever M, Rasic F et al.. Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A Review · Pharmaceuticals (Basel) (2024) · PMID 39204186
  22. Józwiak M, Bauer M, Kamysz W et al.. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review · Pharmaceuticals (Basel) (2025) · PMID 40005999
  23. Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans · Gut (2019) · PMID 31076401
  24. Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing · Cell Tissue Res (2019) · PMID 30915550
  25. Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance · Sports Med (2026) · PMID 41966639
  26. Djakovic Z, Djakovic I, Cesarec V et al.. Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME · World J Gastroenterol (2016) · PMID 27895400
  27. Hrelec M, Klicek R, Brcic L et al.. Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy · J Physiol Pharmacol (2009) · PMID 20388960
  28. Japjec M, Horvat Pavlov K, Petrovic A et al.. Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats · Biomedicines (2021) · PMID 34829776
  29. Matek D, Matek I, Japjec M et al.. Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review · Pharmaceuticals (Basel) (2026) · PMID 41754849
  30. Mayfield CK, Bolia IK, Feingold CL et al.. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians · Am J Sports Med (2026) · PMID 41476424
  31. Biçer O, Adanir O, Güleryüz Y et al.. Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study · Jt Dis Relat Surg (2026) · PMID 42542926
  32. Mikus D, Sikiric P, Seiwerth S et al.. Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice · Burns (2001) · PMID 11718984
  33. Weber C, Krug O, Kamber M, Thevis M. Qualitative and Semiquantitative Analysis of Doping Products Seized at the Swiss Border · Subst Use Misuse (2017) · PMID 28156209
  34. Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review · HSS J (2025) · PMID 40756949

Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.

Important safety information

+

Possible side effects

• Mild redness or swelling at injection site
• Temporary fatigue or headache
• Mild nausea (uncommon)
• Slight dizziness on first dose (rare)

Do not use if you have

• Active cancer or history of cancer (unless approved by oncologist)
• Pregnancy or breastfeeding
• Severe kidney or liver disease
• Known allergy to the peptide or excipients

If you experience severe side effects, call 911 or go to your nearest emergency room.

How supplied

5 mL multi-dose vial, BPC-157 1 mg/mL (5 mg BPC-157 per vial); as the Pen: 3 mL pre-filled Pen cartridge containing 9 mg BPC-157

Common questions

Frequently asked
about BPC-157 (Injectable).

Body Protection Compound-157 supports tissue healing, gut repair, and recovery from injuries. BPC-157 is prescription-only at Pepti: a licensed physician reviews your assessment and, if appropriate, prescribes it to be compounded by a state-licensed, FDA-registered pharmacy.

33 more questions about Pepti, answered.

One vial is your monthly supply at the dose your physician prescribes. A fresh vial ships about every 28 days, and the date moves if your physician changes your dose. Store it as the pharmacy label directs, refrigerated.

Read next

Questions people ask
about BPC-157 (Injectable).

Get started today

Ready to start with BPC-157 (Injectable)?

Free assessment. Licensed physicians. Money-back guarantee if not approved.

Money-back guarantee
Free shipping
Cancel anytime
HSA/FSA accepted
Start free assessment
Total care.
In your pocket.

Message your medical team, track every order, chart every lab marker. 5.0 on the App Store.

Get the app
A hand holding an iPhone showing the Pepti app
Pharmacy network accreditation

PCAB-accredited pharmacies on every order.

Every fulfillment runs through a PCAB-accredited pharmacy.

See the lab results
PCAB — Pharmacy Compounding Accreditation Board · Accredited
  • Rigorous third-party quality & safety inspections
  • Cleanliness and sterile processes
  • Proper ingredient sourcing
  • Accurate dosing and formulation
  • Staff training and procedures
  • Accredited by NABP & ACHC